UVMAN Ultraviolet Products Bcm1,Blog Transmission dynamics of Monkeypox virus: a mathematical modelling approach

Transmission dynamics of Monkeypox virus: a mathematical modelling approach

Monkeypox (MPX), similar to both smallpox and cowpox, is caused by the monkeypox virus (MPXV). It occurs mostly in remote Central and West African communities, close to tropical rain forests. It is caused by the monkeypox virus in the Poxviridae family, which belongs to the genus Orthopoxvirus. We develop and analyse a deterministic mathematical model for the monkeypox virus. Both local and global asymptotic stability conditions for disease-free and endemic equilibria are determined.
It is shown that the model undergo backward bifurcation, where the locally stable disease-free equilibrium co-exists with an endemic equilibrium. Furthermore, we determine conditions under which the disease-free equilibrium of the model is globally asymptotically stable. Finally, numerical simulations to demonstrate our findings and brief discussions are provided. The findings indicate that isolation of infected individuals in the human population helps to reduce disease transmission.

Monkeypox

Monkeypox virus was first isolated and identified in 1958 when monkeys shipped from Singapore to a Denmark research facility fell ill. However, the first confirmed human case was in 1970 when the virus was isolated from a child in the Democratic Republic of Congo suspected to have smallpox.
Coincident immunity to monkeypox virus was previously achieved with vaccinia vaccination; however, eradicating smallpox and subsequent lack of vaccination efforts paved the way for monkeypox to gain clinical relevance. Furthermore, because most cases of monkeypox occur in rural Africa, suspected underreporting may translate to an underestimation of the potential threat of this pathogen.

Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom

Most reported cases of human monkeypox occur in Central and West Africa, where the causing virus is endemic. We describe the identification and public health response to an imported case of West African monkeypox from Nigeria to the United Kingdom (UK) in May 2021. Secondary transmission from the index case occurred within the family to another adult and a toddler. Concurrent COVID-19-related control measures upon arrival and at the hospital, facilitated detection and limited the number of potential contacts.

Misinformation making a disease outbreak worse: outcomes compared for influenza, monkeypox, and norovirus

Health misinformation can exacerbate infectious disease outbreaks. Especially pernicious advice could be classified as “fake news”: manufactured with no respect for accuracy and often integrated with emotive or conspiracy-framed narratives. We built an agent-based model that simulated separate but linked circulating contagious disease and sharing of health advice (classified as useful or harmful). Such advice has potential to influence human risk-taking behavior and therefore the risk of acquiring infection, especially as people are more likely in observed social networks to share bad advice.
We test strategies proposed in the recent literature for countering misinformation. Reducing harmful advice from 50% to 40% of circulating information, or making at least 20% of the population unable to share or believe harmful advice, mitigated the influence of bad advice in the disease outbreak outcomes. How feasible it is to try to make people “immune” to misinformation or control the spread of harmful advice should be explored.

The genomic history of human monkeypox infections in the Central African Republic between 2001 and 2018

Monkeypox is an emerging infectious disease, which has a clinical presentation similar to smallpox. In the two past decades, Central Africa has seen an increase in the frequency of cases, with many monkeypox virus (MPXV) isolates detected in the Democratic Republic of Congo (DRC) and the Central African Republic (CAR). To date, no complete MPXV viral genome has been published from the human cases identified in the CAR. The objective of this study was to sequence the full genome of 10 MPXV isolates collected during the CAR epidemics between 2001 and 2018 in order to determine their phylogenetic relationships among MPXV lineages previously described in Central Africa and West Africa.
Our phylogenetic results indicate that the 10 CAR isolates belong to three lineages closely related to those found in DRC. The phylogenetic pattern shows that all of them emerged in the rainforest block of the Congo Basin. Since most human index cases in CAR occurred at the northern edge of western and eastern rainforests, transmissions from wild animals living in the rainforest is the most probable hypothesis.
In addition, molecular dating estimates suggest that periods of intense political instability resulting in population movements within the country often associated also with increased poverty may have led to more frequent contact with host wild animals. The CAR socio-economic situation, armed conflicts and ecological disturbances will likely incite populations to interact more and more with wild animals and thus increase the risk of zoonotic spillover.

Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization

A monkeypox outbreak in Nigeria during 2017-2020 provides an illustrative case study for emerging zoonoses. We built a statistical model to simulate declining immunity from monkeypox at 2 levels: At the individual level, we used a constant rate of decline in immunity of 1.29% per year as smallpox vaccination rates fell. At the population level, the cohort of vaccinated residents decreased over time because of deaths and births. By 2016, only 10.1% of the total population in Nigeria was vaccinated against smallpox; the serologic immunity level was 25.7% among vaccinated persons and 2.6% in the overall population.
The substantial resurgence of monkeypox in Nigeria in 2017 appears to have been driven by a combination of population growth, accumulation of unvaccinated cohorts, and decline in smallpox vaccine immunity. The expanding unvaccinated population means that entire households, not just children, are now more susceptible to monkeypox, increasing risk of human-to-human transmission.

Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model

Smallpox, caused by Variola virus (VARV), was eradicated in 1980; however, VARV bioterrorist threats still exist, necessitating readily available therapeutics. Current preparedness activities recognize the importance of oral antivirals and recommend therapeutics with different mechanisms of action. Monkeypox virus (MPXV) is closely related to VARV, causing a highly similar clinical human disease, and can be used as a surrogate for smallpox antiviral testing. The prairie dog MPXV model has been characterized and used to study the efficacy of antipoxvirus therapeutics, including recently approved TPOXX (tecovirimat). Brincidofovir (BCV; CMX001) has shown antiviral activity against double-stranded DNA viruses, including poxviruses.
To determine the exposure of BCV following oral administration to prairie dogs, a pharmacokinetics (PK) study was performed. Analysis of BCV plasma concentrations indicated variability, conceivably due to the outbred nature of the animals. To determine BCV efficacy in the MPXV prairie dog model, groups of animals were intranasally challenged with 9 × 105 plaque-forming units (PFU; 90% lethal dose [LD90]) of MPXV on inoculation day 0 (ID0). Animals were divided into groups based on the first day of BCV treatment relative to inoculation day (ID-1, ID0, or ID1). A trend in efficacy was noted dependent upon treatment initiation (57% on ID-1, 43% on ID0, and 29% on ID1) but was lower than demonstrated in other animal models. Analysis of the PK data indicated that BCV plasma exposure (maximum concentration [C max]) and the time of the last quantifiable concentration (AUClast) were lower than in other animal models administered the same doses, indicating that suboptimal BCV exposure may explain the lower protective effect on survival.

Human Monkeypox Virus IgG (MPXV IgG) ELISA Kit

abx392298-100g Abbexa 100 µg 593.75 EUR

Human Monkeypox Virus IgG (MPXV IgG) ELISA Kit

abx092187-100l Abbexa 100 µl 525 EUR

Human Monkeypox Virus IgG (MPXV IgG) ELISA Kit

abx092187-1ml Abbexa 1 ml Ask for price

Human Monkeypox Virus IgG (MPXV IgG) ELISA Kit

abx092187-200l Abbexa 200 µl Ask for price

Monkeypox Virus (MPXV) IgG ELISA Ki

MBS2569817-5x96Tests MyBiosource 5x96Tests 2140 EUR

Monkeypox Virus (MPXV) IgG ELISA Ki

MBS2569817-96Tests MyBiosource 96Tests 475 EUR

Monkeypox Virus -MPXV- IgG ELISA Kit

E-EL-E620-24Tests Elabscience Biotech 24 Tests Ask for price

Monkeypox Virus -MPXV- IgG ELISA Kit

E-EL-E620-48Tests Elabscience Biotech 48 Tests Ask for price

Monkeypox Virus -MPXV- IgG ELISA Kit

E-EL-E620-96Tests Elabscience Biotech 96 Tests 500 EUR

Monkeypox Virus -MPXV- IgG ELISA Kit

E-EL-E620-96Tests10 Elabscience Biotech 96 Tests *10 5000 EUR

Monkeypox Virus -MPXV- IgG ELISA Kit

E-EL-E620-96Tests5 Elabscience Biotech 96 Tests *5 2500 EUR

Human Monkeypox IgG/IgM Lateral Flow Assay Kit

MBS2569815-20Tests MyBiosource 20Tests 265 EUR

Human Monkeypox IgG/IgM Lateral Flow Assay Kit

MBS2569815-50Tests MyBiosource 50Tests 445 EUR

Human Monkeypox Virus M1R IgG (MPXV M1R IgG) ELISA Kit

abx395182-100g Abbexa 100 µg 812.5 EUR

Human Monkeypox Virus H3L IgG (MPXV H3L IgG) ELISA Kit

abx395183-25g Abbexa 25 µg 812.5 EUR

Human Monkeypox Virus E8L IgG (MPXV E8L IgG) ELISA Kit

abx395184-50g Abbexa 50 µg 812.5 EUR

Human Monkeypox Virus A29L IgG (MPXV A29L IgG) ELISA Kit

abx395181-50g Abbexa 50 µg 812.5 EUR

Human Monkeypox Virus A35R IgG (MPXV A35R IgG) ELISA Kit

abx395185-100g Abbexa 100 µg 812.5 EUR

Human Monkeypox Virus IgG/IgM (MPXV IgG/IgM) Rapid Test Kit

abx092183-100l Abbexa 100 µl 1000 EUR

Human Monkeypox Virus IgG/IgM (MPXV IgG/IgM) Rapid Test Kit

abx092183-1ml Abbexa 1 ml 12000 EUR

Human Monkeypox Virus IgG/IgM (MPXV IgG/IgM) Rapid Test Kit

abx092183-200l Abbexa 200 µl 3500 EUR

Monkeypox B5R

mpv-002 ProSpec Tany 100µg 200 EUR

Monkeypox A33R

mpv-001 ProSpec Tany 100µg 200 EUR

Monkeypox virus

Oneq-VH747-OneqVH747100D Bioingentech Oneq-VH747-100D 515 EUR

Monkeypox virus

Oneq-VH747-OneqVH747150D Bioingentech Oneq-VH747-150D 594 EUR

Monkeypox virus

Oneq-VH747-OneqVH74750D Bioingentech Oneq-VH747-50D 413 EUR

Recombinant Monkeypox B5R

MBS141734-01mg MyBiosource 0.1mg 360 EUR

Recombinant Monkeypox B5R

MBS141734-05mg MyBiosource 0.5mg 960 EUR

Recombinant Monkeypox B5R

MBS141734-1mg MyBiosource 1mg 1565 EUR

Recombinant Monkeypox B5R

MBS141734-5x1mg MyBiosource 5x1mg 6715 EUR

Recombinant Monkeypox A33R

MBS141733-01mg MyBiosource 0.1mg 360 EUR

Recombinant Monkeypox A33R

MBS141733-05mg MyBiosource 0.5mg 960 EUR

Recombinant Monkeypox A33R

MBS141733-1mg MyBiosource 1mg 1565 EUR

Recombinant Monkeypox A33R

MBS141733-5x1mg MyBiosource 5x1mg 6715 EUR

Recombinant Monkeypox Virus antigen

E41H094 EnoGene 100ug 495 EUR

Recombinant Monkeypox Virus antigen

E41H095 EnoGene 100ug 495 EUR

Mouse Anti Monkeypox Virus E8L Monoclonal Clone SAA0285

IMSAMPXVE8LSAA0285C100UG Innovative research each 354 EUR

Mouse Anti Monkeypox Virus E8L Monoclonal Clone SAA0285

IMSAMPXVE8LSAA0285C1MG Innovative research each 1417 EUR

Mouse Anti Monkeypox Virus H3L Monoclonal Clone SAA0282

IMSAMPXVH3LSAA0282C100UG Innovative research each 354 EUR

Mouse Anti Monkeypox Virus H3L Monoclonal Clone SAA0282

IMSAMPXVH3LSAA0282C1MG Innovative research each 1417 EUR

Mouse Anti Monkeypox Virus M1R Monoclonal Clone SAA0283

IMSAMPXVM1RSAA0283C100UG Innovative research each 354 EUR

Mouse Anti Monkeypox Virus M1R Monoclonal Clone SAA0283

IMSAMPXVM1RSAA0283C1MG Innovative research each 1417 EUR

Mouse Anti Monkeypox Virus M1R Monoclonal Clone SAA0284

IMSAMPXVM1RSAA0284C100UG Innovative research each 354 EUR

Mouse Anti Monkeypox Virus M1R Monoclonal Clone SAA0284

IMSAMPXVM1RSAA0284C1MG Innovative research each 1417 EUR

Mouse Anti Monkeypox Virus E8L Monoclonal Clone SAA0285

MBS8430460-INQUIRE MyBiosource INQUIRE Ask for price

Mouse Anti Monkeypox Virus M1R Monoclonal Clone SAA0283

MBS8430461-INQUIRE MyBiosource INQUIRE Ask for price

Mouse Anti Monkeypox Virus M1R Monoclonal Clone SAA0284

MBS8430462-INQUIRE MyBiosource INQUIRE Ask for price

Mouse Anti Monkeypox Virus H3L Monoclonal Clone SAA0282

MBS8421692-01mg MyBiosource 0.1mg 540 EUR

Mouse Anti Monkeypox Virus H3L Monoclonal Clone SAA0282

MBS8421692-1mg MyBiosource 1mg 1835 EUR

Mouse Anti Monkeypox Virus H3L Monoclonal Clone SAA0282

MBS8421692-5x1mg MyBiosource 5x1mg 8030 EUR

Mouse Anti Monkeypox Virus A29L Monoclonal Clone SAA0286

IMSAMPXVA29LSAA0286C100UG Innovative research each 354 EUR

Mouse Anti Monkeypox Virus A29L Monoclonal Clone SAA0286

IMSAMPXVA29LSAA0286C1MG Innovative research each 1417 EUR

Mouse Anti Monkeypox Virus A35R Monoclonal Clone SAA0287

IMSAMPXVA35RSAA0287C100UG Innovative research each 354 EUR

Mouse Anti Monkeypox Virus A35R Monoclonal Clone SAA0287

IMSAMPXVA35RSAA0287C1MG Innovative research each 1417 EUR

Mouse Anti Monkeypox Virus A29L Monoclonal Clone SAA0286

MBS8430458-INQUIRE MyBiosource INQUIRE Ask for price

Mouse Anti Monkeypox Virus A35R Monoclonal Clone SAA0287

MBS8430459-INQUIRE MyBiosource INQUIRE Ask for price

Monkeypox Virus (MPXV-A29L) Antibody

MBS5680248-02mg MyBiosource 0.2mg 725 EUR

Monkeypox Virus (MPXV-A29L) Antibody

MBS5680248-5x02mg MyBiosource 5x0.2mg 3055 EUR

Monkeypox Virus (MPXV-A29L) Antibody

MBS5680249-02mg MyBiosource 0.2mg 725 EUR

Monkeypox Virus (MPXV-A29L) Antibody

MBS5680249-5x02mg MyBiosource 5x0.2mg 3055 EUR

EasyNAT Monkeypox Virus Assay

U202028 USTAR Biotechnologies (Hangzhou) test Ask for price

Monkeypox Virus H3L Recombinant Antigen

MBS318941-05mg MyBiosource 0.5mg 1775 EUR

Monkeypox Virus H3L Recombinant Antigen

MBS318941-5x05mg MyBiosource 5x0.5mg 7740 EUR

Monkeypox Virus P4a Recombinant Antigen

MBS318942-05mg MyBiosource 0.5mg 1775 EUR

Monkeypox Virus P4a Recombinant Antigen

MBS318942-5x05mg MyBiosource 5x0.5mg 7740 EUR

Monkeypox virus L1R, His Tag

S0A2002 Starter Biotechnology Co Ltd
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 µg
  • 1 mg
  • 25 µg
  • 500 µg
  • 50 µg
  • 100 µg

Monkeypox virus M1R, His Tag

S0A2014 Starter Biotechnology Co Ltd
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 µg
  • 1 mg
  • 25 µg
  • 500 µg
  • 50 µg
  • 100 µg

Monkeypox Virus H3L (MPXV H3L) Antibody

abx376562-96tests Abbexa 96 tests 368.75 EUR

Monkeypox Virus M1R (MPXV M1R) Antibody

abx376563-96tests Abbexa 96 tests 368.75 EUR

Monkeypox Virus M1R (MPXV M1R) Antibody

abx376564-96tests Abbexa 96 tests 368.75 EUR

Monkeypox Virus, 20 tests/kit

U202028-20 USTAR Biotechnologies (Hangzhou) test Ask for price

Monkeypox virus A35R, His Tag

S0A2009 Starter Biotechnology Co Ltd
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 µg
  • 1 mg
  • 25 µg
  • 500 µg
  • 50 µg
  • 100 µg

Monkeypox virus A35R, His Tag

S0A2013 Starter Biotechnology Co Ltd
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 µg
  • 1 mg
  • 25 µg
  • 500 µg
  • 50 µg
  • 100 µg

MonkeyPox Virus (MPV) ELISA Kit

SL0026Mk Sunlong - Ask for price

MonkeyPox Virus (MPV) ELISA Kit

YX-SL0036Mk Sunlong - Ask for price

Monkeypox Virus A29L (MPXV A29L) Antibody

abx376566-96tests Abbexa 96 tests 368.75 EUR

Monkeypox Virus A29L (MPXV A29L) Antibody

abx345842-100l Abbexa 100 µl 350 EUR

Monkeypox Virus A29L (MPXV A29L) Antibody

abx345842-50l Abbexa 50 µl 250 EUR

Monkeypox Virus (MPXV) A29L Protein

A29L-EC Novatein Biosciences, Inc. 100 µg Ask for price

Monkeypox Virus (MPXV) A29L Protein

A29L-HEK Novatein Biosciences, Inc. 100 µg Ask for price

Monkeypox Virus (MPXV) A35R Protein

A35R-EC Novatein Biosciences, Inc. 100 µg Ask for price

Monkeypox Virus (MPXV) A35R Protein

A35R-HEK Novatein Biosciences, Inc. 100 µg Ask for price

Recombinant Monkeypox Virus Antigen (His tag)

MBS2569814-1mg MyBiosource 1mg 1050 EUR

Rabbit Anti Monkeypox Virus A30L Polyclonal Antigen Affinity Purified

IRBAMPXVA30LAAP100UG Innovative research each 296 EUR

Rabbit Anti Monkeypox Virus B6R Polyclonal Antigen Affinity Purified

IRBAMPXVB6RAAP100UG Innovative research each 296 EUR

Rabbit Anti Monkeypox Virus B6R Polyclonal Antigen Affinity Purified

MBS8421689-01mg MyBiosource 0.1mg 445 EUR

Rabbit Anti Monkeypox Virus A30L Polyclonal Antigen Affinity Purified

MBS8421690-01mg MyBiosource 0.1mg 445 EUR

Monkeypox Virus (MPXV) H3L Antigen ELISA Kit

MBS1564873-5x96Tests MyBiosource 5x96Tests 4500 EUR

Monkeypox Virus (MPXV) H3L Antigen ELISA Kit

MBS1564873-96Tests MyBiosource 96Tests 975 EUR

Monkeypox Virus (MPXV) E8L Antigen ELISA Kit

MBS1564875-5x96Tests MyBiosource 5x96Tests 4500 EUR

Monkeypox Virus (MPXV) E8L Antigen ELISA Kit

MBS1564875-96Tests MyBiosource 96Tests 975 EUR

Monkeypox Virus (MPXV) M1R Antigen ELISA Kit

MBS1564876-5x96Tests MyBiosource 5x96Tests 4500 EUR

Monkeypox Virus (MPXV) M1R Antigen ELISA Kit

MBS1564876-96Tests MyBiosource 96Tests 975 EUR

Native Monkeypox virus A35R protein

A35R-01M Creative BioMart 100ug 3198.4 EUR

Monkeypox Virus (MPXV) A35R Antigen ELISA Kit

MBS1564874-5x96Tests MyBiosource 5x96Tests 4500 EUR

Monkeypox Virus (MPXV) A35R Antigen ELISA Kit

MBS1564874-96Tests MyBiosource 96Tests 975 EUR

Monkeypox Virus (MPXV) A29L Antigen ELISA Kit

MBS1564877-5x96Tests MyBiosource 5x96Tests 4500 EUR

Monkeypox Virus (MPXV) A29L Antigen ELISA Kit

MBS1564877-96Tests MyBiosource 96Tests 975 EUR

Monkeypox Virus (MPXV) A35 Antibody, Mouse MAb

MBS8124472-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A35 Antibody, Mouse MAb

MBS8124472-01mL MyBiosource 0.1mL 385 EUR

Monkeypox Virus (MPXV) A35 Antibody, Mouse MAb

MBS8124472-5x01mL MyBiosource 5x0.1mL 1590 EUR

Monkeypox Virus (MPXV) A35 Antibody, Mouse MAb

MBS8124473-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A35 Antibody, Mouse MAb

MBS8124473-01mL MyBiosource 0.1mL 385 EUR

Monkeypox Virus (MPXV) A35 Antibody, Mouse MAb

MBS8124473-5x01mL MyBiosource 5x0.1mL 1590 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124475-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124475-01mL MyBiosource 0.1mL 385 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124475-5x01mL MyBiosource 5x0.1mL 1590 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124476-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124476-01mL MyBiosource 0.1mL 385 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124476-5x01mL MyBiosource 5x0.1mL 1590 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124477-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124477-01mL MyBiosource 0.1mL 415 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124477-5x01mL MyBiosource 5x0.1mL 1710 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124478-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124478-01mL MyBiosource 0.1mL 415 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124478-5x01mL MyBiosource 5x0.1mL 1710 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124479-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124479-01mL MyBiosource 0.1mL 415 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124479-5x01mL MyBiosource 5x0.1mL 1710 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124480-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124480-01mL MyBiosource 0.1mL 385 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124480-5x01mL MyBiosource 5x0.1mL 1590 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124481-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124481-01mL MyBiosource 0.1mL 385 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124481-5x01mL MyBiosource 5x0.1mL 1590 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124482-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124482-01mL MyBiosource 0.1mL 385 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124482-5x01mL MyBiosource 5x0.1mL 1590 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124483-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124483-01mL MyBiosource 0.1mL 385 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124483-5x01mL MyBiosource 5x0.1mL 1590 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124484-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124484-01mL MyBiosource 0.1mL 385 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124484-5x01mL MyBiosource 5x0.1mL 1590 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124485-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124485-01mL MyBiosource 0.1mL 385 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124485-5x01mL MyBiosource 5x0.1mL 1590 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124486-002mL MyBiosource 0.02mL 240 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124486-01mL MyBiosource 0.1mL 385 EUR

Monkeypox Virus (MPXV) A29 Antibody, Mouse MAb

MBS8124486-5x01mL MyBiosource 5x0.1mL 1590 EUR

Monkeypox Virus (MPXV) A5L Antibody, Mouse MAb

MBS8124544-002mL MyBiosource 0.02mL 175 EUR

Monkeypox Virus (MPXV) A5L Antibody, Mouse MAb

MBS8124544-01mL MyBiosource 0.1mL 365 EUR

Monkeypox Virus (MPXV) A5L Antibody, Mouse MAb

MBS8124544-5x01mL MyBiosource 5x0.1mL 1500 EUR

Monkeypox Virus (MPXV) RT-PCR Kit

abx471001-1096tests Abbexa 10 × 96 tests Ask for price

Monkeypox Virus (MPXV) RT-PCR Kit

abx471001-596tests Abbexa 5 × 96 tests Ask for price

Monkeypox Virus (MPXV) RT-PCR Kit

abx471001-96tests Abbexa 96 tests 2550 EUR

Monkeypox Virus Real Time PCR Kit

PDPS-AR064 Creative Biogene 1 unit Ask for price

Monkeypox Virus Real Time PCR Kit

ZD-0076-01 Gentaur Genprice 25 tests/kit Ask for price

Monkeypox Virus Real Time PCR Kit

ZD-0076-02 Gentaur Genprice 25 tests/kit Ask for price

Monkeypox Virus Real Time PCR Kit

YJC70115NW-25T Jiangsu Bioperfectus Technologies 25 tests/kit Ask for price

Human Monkeypox Virus Antigen (MPXV) ELISA Kit

abx365123-100g Abbexa 100 µg 618.75 EUR

Monkeypox C19L protein (C-His tag)

EGPS018D-50 EnoGene Monkeypox 206.5 EUR

Monkeypox Virus (MPXV) A29 ELISA Kit

MBS8124546-5x96Tests MyBiosource 5x96Tests 3465 EUR

Monkeypox Virus (MPXV) A29 ELISA Kit

MBS8124546-96Tests MyBiosource 96Tests 750 EUR

Monkeypox Virus (MPXV) E8L ELISA Kit

MBS9145476-005mL MyBiosource 0.05mL 210 EUR

Monkeypox Virus (MPXV) E8L ELISA Kit

MBS9145476-01mL MyBiosource 0.1mL 285 EUR

Monkeypox Virus (MPXV) E8L ELISA Kit

MBS9145476-02mL MyBiosource 0.2mL 430 EUR

Monkeypox Virus (MPXV) E8L ELISA Kit

MBS9145476-5x02mL MyBiosource 5x0.2mL 1790 EUR

Monkeypox Virus (MPXV) E8L ELISA Kit

MBS9145476-96Tests MyBiosource 96Tests 570 EUR
IMPORTANCE Preparedness activities against highly transmissible viruses with high mortality rates have been highlighted during the ongoing coronavirus disease 2019 (COVID-19) pandemic. Smallpox, caused by variola virus (VARV) infection, is highly transmissible, with an estimated 30% mortality. Through an intensive vaccination campaign, smallpox was declared eradicated in 1980, and routine smallpox vaccination of individuals ceased. Today’s current population has little/no immunity against VARV. If smallpox were to reemerge, the worldwide results would be devastating.
Recent FDA approval of one smallpox antiviral (tecovirimat) was a successful step in biothreat preparedness; however, orthopoxviruses can become resistant to treatment, suggesting the need for multiple therapeutics. Our paper details the efficacy of the investigational smallpox drug brincidofovir in a monkeypox virus (MPXV) animal model. Since brincidofovir has not been tested in vivo against smallpox, studies with the related virus MPXV are critical in understanding whether it would be protective in the event of a smallpox outbreak.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

Achieving Short-Wavelength Phase-Matching Second Harmonic Generation in Boron-Rich Borosulfate with Planar [BO3] Units

Achieving Short-Wavelength Phase-Matching Second Harmonic Generation in Boron-Rich Borosulfate with Planar [BO3] UnitsAchieving Short-Wavelength Phase-Matching Second Harmonic Generation in Boron-Rich Borosulfate with Planar [BO3] Units

Ultraviolet (UV) nonlinear optical (NLO) crystals which may produce short-wavelength lasers through a direct second harmonic technology (SHG) course of are of nice significance in fashionable laser expertise. At the moment,